Metformin Administered Without Diabetes Diagnosis The research was performed entirely as a community-based study using ...

The diabetes drug metformin provided overweight/obese patients with osteoarthritis (OA) of the knee with significantly ...

MM-II is based on a proprietary suspension of large, empty, multilamellar liposomes designed to reduce joint friction and ...

A group of Australian pet owners who say their dogs suffered adverse effects or died after receiving an osteoarthritis ...

India's Sun Pharma and Israel's Moebius Medical published new data on MM-II, a non-opioid treatment for knee osteoarthritis.

II, a non-opioid treatment for knee osteoarthritis. Published in Osteoarthritis and Cartilage journal, the study reveals that ...

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying ...

Osteoarthritis is the leading cause of disability and chronic pain worldwide, affecting an estimated 595 million people globally. Projections suggest that this number will rise to 1 billion by 2050.

Now, researchers from the University of Wisconsin–Madison may have found a solution in the form of an existing arthritis drug. Testing the drug, called tofacitinib, in mouse models of epilepsy, they ...

The FDA raises red flags about a widely-used dog arthritis treatment after thousands of adverse reactions, including deaths ...

The Osteoarthritis Pain Drugs Market encompasses a wide variety of pharmaceutical products aimed at alleviating pain, reducing inflammation, and improving joint mobility. These drugs are essential for ...